Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Arruda

Showing results (1-10 of 185) with videos related to

Pageof 19
Sort By:
Worldaids|September 1, 1994
A moral dilemmaR Arruda
Haematologica|July 2, 2015
The search for the origin of factor VIII synthesis and its impact on therapeutic strategies for hemophilia AValder R Arruda
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 19, 2007
The role of immunosuppression in gene- and cell-based treatments for duchenne muscular dystrophyValder R Arruda
Blood Advances|October 26, 2021
Why is AAV FVIII gene therapy not approved by the US Food and Drug Administration yet?Valder R Arruda
Revista Brasileira De Hematologia E Hemoterapia|October 10, 2013
A novel strategy for the screening for platelet refractoriness: prospects and limitationsValder R Arruda
Blood|April 15, 2017
Stopping bleeding is not enough to FIX hemarthropathyValder R Arruda
Journal of Thrombosis and Haemostasis : JTH|May 19, 2006
Toward gene therapy for hemophilia A with novel adenoviral vectors: successes and limitations in canine modelsV R Arruda
Medicine and Health, Rhode Island|September 7, 2000
To sue or not to sue: an attorney's perspectiveM Wistow, R Arruda
Journal of Thrombosis and Haemostasis : JTH|January 24, 2007
It's all about the clothing: capsid domination in the adeno-associated viral vector worldV R Arruda, W Xiao
Therapeutic Advances in Hematology|September 14, 2018
Gene therapy for hemophilia: what does the future hold?Bhavya S Doshi, Valder R Arruda
Pageof 19

Showing results (1-10 of 185) with videos related to

Sort By:
Pageof 19
Worldaids|September 1, 1994
A moral dilemmaR Arruda
Haematologica|July 2, 2015
The search for the origin of factor VIII synthesis and its impact on therapeutic strategies for hemophilia AValder R Arruda
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 19, 2007
The role of immunosuppression in gene- and cell-based treatments for duchenne muscular dystrophyValder R Arruda
Blood Advances|October 26, 2021
Why is AAV FVIII gene therapy not approved by the US Food and Drug Administration yet?Valder R Arruda
Revista Brasileira De Hematologia E Hemoterapia|October 10, 2013
A novel strategy for the screening for platelet refractoriness: prospects and limitationsValder R Arruda
Blood|April 15, 2017
Stopping bleeding is not enough to FIX hemarthropathyValder R Arruda
Journal of Thrombosis and Haemostasis : JTH|May 19, 2006
Toward gene therapy for hemophilia A with novel adenoviral vectors: successes and limitations in canine modelsV R Arruda
Medicine and Health, Rhode Island|September 7, 2000
To sue or not to sue: an attorney's perspectiveM Wistow, R Arruda
Journal of Thrombosis and Haemostasis : JTH|January 24, 2007
It's all about the clothing: capsid domination in the adeno-associated viral vector worldV R Arruda, W Xiao
Therapeutic Advances in Hematology|September 14, 2018
Gene therapy for hemophilia: what does the future hold?Bhavya S Doshi, Valder R Arruda
Pageof 19